XFOR — X4 Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $317.27m
- $186.06m
- $35.11m
X4 Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: X4 Pharmaceuticals Q2 Operating Expenses USD 25.197 Million
X4 Pharmaceuticals Inc expected to post a loss of 18 cents a share - Earnings Preview
Brief: X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule
Brief: X4 Pharmaceuticals Inc - May Offer Up To $300 Million Of Common Stock, Preferred Stock, Debt Securities, Warrants, And/Or Units - SEC Filing
X4 Pharmaceuticals posts Q1 net loss as license revenue drops
Brief: X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Rare disease drugmaker X4 Pharma's Q4 revenue rises on XOLREMDI strength
Brief: X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule
X4 Pharma Q3 net loss narrows to $29.8 mln
U.S. STOCKS ON THE MOVE-GrafTech, Nextracker, Alpha and Omega, Coinbase
U.S. STOCKS ON THE MOVE-GrafTech, Nextracker, Alpha and Omega
X4 Pharma rallies nearly 50% after $135 mln share offering
U.S. STOCKS ON THE MOVE-Cipher Mining, Kura, GrafTech
U.S. STOCKS ON THE MOVE-Alphabet, Ford, Procter & Gamble
X4 Pharma falls after $135 mln equity offering
Brief: X4 Pharmaceuticals Announces Pricing Of $135 Million Underwritten Public Offering At $2.90 Per Share
Brief: X4 Pharmaceuticals Announces Proposed Underwritten Public Offering
X4 Pharma slips on launching stock offering